Results 31 to 40 of about 102,651 (313)
Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]
, 2014 Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
Camm, AJ +3 more
core +1 more source
Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update
PharmaceuticsDirect oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed
Anabel Franco-Moreno +4 more
doaj +1 more source
THALASSEMIA AND VENOUS THROMBOEMBOLISM
Mediterranean Journal of Hematology and Infectious Diseases, 2011 Although the life expectancy of thalassemia patients has markedly improved over the last few decades, patients still suffer from many complications of this congenital disease. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients.
Khaled M. Musallam +2 more
openaire +5 more sources
Haematologica, 2012 Background Studies evaluating risk factors for in-hospital venous thromboembolism in children are limited by quality assurance of case definition and/or lack of controlled comparison.
Brian R. Branchford +5 more
doaj +1 more source
Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
Thrombosis Journal, 2020 Background The role of venous obstructions as a risk factor for recurrent venous thromboembolism has never been evaluated. This study aimed to determine whether there is a difference in prevalence of venous obstructions between patients with and without ...
Pascale Notten +4 more
doaj +1 more source
, 2019 Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1_(2) for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748) +7 more
core +1 more source
Simple measures can improve care in our hospitals : an audit of venous thromboembolism practice [PDF]
, 2013 : Venous thromboembolism (VTE) is a serious but preventable complication of hospitalisation. Doctors still sometimes fail to adhere to them, thus putting patients at risk and incurring considerable expense for the national health service.
Azzopardi, Stephanie +3 more
core
, 2019 Supplemental Material, Supplemental-Materials-Venous-thromboembolism-in-NICU-REV1 for Venous Thromboembolism in Neurocritical Care Patients by Tanuwong Viarasilpa, Nicha Panyavachiraporn, Jack Jordan, Seyed Mani Marashi, Meredith van Harn, Noel O ...
Jack Jordan (6679748) +7 more
core +1 more source
Development and validation of a risk prediction model for venous thromboembolism in postpartum women: A multinational cohort study [PDF]
, 2016 Objective To develop and validate a risk prediction model for venous thromboembolism in the first six weeks after delivery (early postpartum).Design Cohort study.Setting Records from England based Clinical Practice Research Datalink (CPRD) linked to ...
core +1 more source
Arthritis Care &Research, EarlyView.Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli +10 more
wiley +1 more source